MYRIAD GENETICS, INC. (MYGN) Operating cash flow 2016–2025
MYRIAD GENETICS, INC. (MYGN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$1.8MFY2025 · since FY2016: $166.3M → $1.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.8M | +120.7% |
| FY2024 | -$8.7M | +92.2% |
| FY2023 | -$110.9M | -4.3% |
| FY2022 | -$106.3M | -671.5% |
| FY2021 | $18.6M | -69.4% |
| FY2020 | $60.7M | -27.5% |
| FY2019 | $83.7M | -27.8% |
| FY2018 | $115.9M | +9.1% |
| FY2017 | $106.2M | -36.1% |
| FY2016 | $166.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice